Subscribe to our Newsletters !!
How are viruses different from bacteria apex ? O
When it comes to nanoscience, Transmission Electro
Insects that are given more attention and reverenc
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German spouse BioNTech and raised its full-year profit forecast.
The company said it expects total 2021 earnings of between $59.4 billion and $61.4 billion.
The vaccine was among the first to be authorized for emergency use in the USA and various other countries, and analysts have forecast billions in sales.
In the fourth quarter, the vaccine brought in sales of $154 million, below expectations of $462 million, according to consensus estimates compiled by brokerage Mizuho.
The company now expects full-year adjusted earnings of $3.10 to $3.20 per share, up from its prior forecast of $3 to $3.10 per share.
